Funds · PYXS

Who owns PYXS?

Institutional ownership of Pyxis Oncology Inc. from Form 13F, Q2 2026

76 institutional managers reported holding Pyxis Oncology Inc. (PYXS) in Form 13F filings for Q2 2026, with 34,152,124 shares worth $101M. The largest reported holder was GordonMD Global Investments LP. Managers that filed both quarters added a net 6,592,533 shares (+23.9%). 10 opened new positions and 10 sold out.

Funds holding
76
Value held
$101M
New / sold out
10 / 10
Net shares, same filers
+23.9%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of PYXS

FundValueShare of 13F holdingsSharesMove
GordonMD Global Investments LP$30.2M29.4%10,024,909Added
Pfizer Inc$19.5M20.6%7,032,770Unchanged
Laurion Capital Management LP$14.8M14.4%4,900,888Trimmed
Vanguard Capital Management LLC$6.2M6.1%2,075,997Added
Atle Fund Management AB$2.9M2.8%966,459Added
BlackRock, Inc.$2.6M2.5%867,934Added
Palo Alto Investors LP$2.6M2.5%864,277Trimmed
Marshall Wace, LLP$2.5M2.4%830,544Added
Renaissance Technologies LLC$2.3M2.3%772,232Trimmed
Geode Capital Management, LLC$1.8M1.7%591,849Trimmed
Woodline Partners LP$1.6M1.5%523,999New
683 Capital Management, LLC$1.4M1.3%459,367Trimmed
Jacobs Levy Equity Management, Inc$1.3M1.3%428,606Trimmed
Longaeva Partners L.P.$1.1M1.0%353,582Trimmed
Decheng Capital LLC$984K1.0%326,810Unchanged
Vanguard Fiduciary Trust Co$912K0.9%302,986Added
Jane Street Group, LLC$873K0.8%290,090Trimmed
State Street Corp$749K0.7%248,837Unchanged
Millennium Management LLC$701K0.7%233,004Trimmed
UBS Group AG$467K0.5%155,217Trimmed
Bank of New York Mellon Corp$403K0.4%133,996Unchanged
Acadian Asset Management LLC$380K0.4%126,793Trimmed
Northern Trust Corp$373K0.4%123,959Added
NewEdge Wealth, LLC$349K0.3%116,006Unchanged
XTX Topco Ltd$334K0.3%110,939Trimmed

Share of 13F holdings is each fund's shares as a share of the 34,152,124 PYXS shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. GordonMD Global Investments LP Added+$17.8M
  2. Atle Fund Management AB Added+$2.3M
  3. Woodline Partners LP New+$1.6M
  4. Marshall Wace, LLP Added+$1.4M
  5. BlackRock, Inc. Added+$238K
  6. Bank of America Corp Added+$192K
  7. MYDA Advisors LLC New+$151K
  8. Quadrature Capital Ltd New+$142K
  9. Verdad Advisers, LP New+$135K
  10. Vanguard Capital Management LLC Added+$128K

Biggest sellers in Q2 2026

  1. 683 Capital Management, LLC Trimmed-$1.3M
  2. Millennium Management LLC Trimmed-$496K
  3. Longaeva Partners L.P. Trimmed-$450K
  4. Palo Alto Investors LP Trimmed-$440K
  5. Renaissance Technologies LLC Trimmed-$351K
  6. UBS Group AG Trimmed-$298K
  7. Laurion Capital Management LP Trimmed-$290K
  8. XTX Topco Ltd Trimmed-$268K
  9. Barclays PLC Trimmed-$136K
  10. Morgan Stanley Trimmed-$109K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $25.0M and sold $4.8M; 24 added and 24 trimmed.

Schedule 13D and 13G filings on PYXS

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about PYXS ownership

Who owns PYXS stock?
76 institutional investment managers reported PYXS positions in their Form 13F filings for Q2 2026, holding 34,152,124 shares worth $101M in total. GordonMD Global Investments LP reported the largest position.
Are funds buying or selling PYXS?
In Q2 2026, 10 managers opened new PYXS positions, 24 added, 24 trimmed and 10 sold out. Managers that filed in both quarters added a net 6,592,533 shares.
How current is this PYXS institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PYXS by CUSIP. Options are left out. PYXS news and filings · PYXS insider trades · Top funds